Aviir Receives $10 Mln Tranche, Partners & Partners Invests

Aviir said Friday that it has secured a third $10 million tranche from a group that includes new investor Partners & Partners. Merck Global Health Innovation Fund led the round while current investors Bay City Capital, Aberdare Ventures, and New Leaf Venture Partners also participated. Total financing for Aviir, a biotechnology company focused on the prevention of cardiovascular disease, comes to $30 million. Inverness Advisors, a division of KEMA Partners LLC, acted as exclusive placement agent.